🏆It can be the difference between getting ahead or being left behind — For many corporates, finding the right Deep Tech startup to co-create innovative solutions with can be tricky. That’s where SGInnovate’s Corporate Engagement team comes in: https://bit.ly/40T3HxI As part of the SGInnovate investments team, they're equipped with knowledge of regional startup trends and insights across domains such as advanced manufacturing and BioMedtech. An extensive network of partners - research institutes and venture capitalists - also gives them an edge when designing bespoke plans to help corporates meet their business goals. Read more about what the team does and how they’ve helped Japanese medical device and pharma company Teijin Limited in the full article. Thank you Akihiro Maeda for your support! Charlotte Tan Kellie Chan Nikita Gupta
SGInnovate’s Post
More Relevant Posts
-
The #EIC #STEP Scale Up scheme is part of the Strategic Technologies for Europe Platform (STEP), offering financial support in the form of investments to #startups, #SMEs, and small mid-caps.
The European Innovation Council and SMEs Executive Agency (EISMEA) is now an even stronger partner for scaling up deep tech in Europe. Is your company: - a deep tech scaleup (up to 499 employees) in Digital and deeptech, Clean Energy or Biotechnology? - seeking an investor that can invest €10 to 30 million for a major funding round? - already having qualified investors covering at least 20% of the target funding round? If yes to all three, check out the European Innovation Council (EIC) STEP ScaleUP scheme that is open to receive business plans and apply here ➡️europa.eu/!CYQcwV The EIC STEP Scale Up scheme is part of the Strategic Technologies for Europe Platform (STEP), offering financial support in the form of investments to startups, SMEs, and small mid-caps.
To view or add a comment, sign in
-
In the complex world of biotech innovation, strategic focus can be your secret weapon. Learn how to cut through the noise, streamline your efforts, and accelerate your path to success. Curious about how strategic focus can transform your startup's journey? Let's explore the possibilities together. #StrategicFocus #BiotechInnovation https://lnkd.in/g5YSS6U3
To view or add a comment, sign in
-
🔍 Want to learn more about deep tech innovation in CEE? Selma El Ouardi, our Investor Network Manager, will be joining the Deep Tech CEE Summit & Challenge today on the Main Stage at the Central House of Technology in Warsaw from 16:15 - 17:20! ✨ The panel discussion she’ll participate in, titled "Scaling Deep Tech: Bridging Innovation and Market Adoption in the CEE Region," will explore pivotal strategies for helping deep tech startups in CEE successfully scale and thrive. The main topics of the discussion include: 📈 Scaling strategies — Insights on corporate acceleration and de-risking investments 🌐 International expansion — Deciding when to prioritize local vs. global market entry 🏢 Corporate & investor roles — How partners like the EIC Accelerator and EIC Fund support the journey from research to market-ready products 🤝 Building solid partnerships — Creating win-win collaborations for sustained growth 💡 Identifying innovations — Spotting promising technologies and structuring smart investments 🌍 Strengthening CEE’s global presence — Enhancing reputation and leveraging platforms like the Warsaw Stock Exchange for funding Joining Selma on the panel: → Michiel Scheffer - President of the European Innovation Council (EIC) Board → Dominykas Stankevicius - Investor Manager, Taiwania Capital → Viktorija Trimbel - Managing Director at Coinvest Capital → Paweł Michalski - CEO, VCLeaders Don’t miss this opportunity to hear from the key players in deep tech investing and learn more about the future of innovation in the CEE region! See you there!
To view or add a comment, sign in
-
Opportunities to fund deep technology scalеup (up to 499 employees) in Digital and deeptech, Clean Energy or Biotechnology
The European Innovation Council and SMEs Executive Agency (EISMEA) is now an even stronger partner for scaling up deep tech in Europe. Is your company: - a deep tech scaleup (up to 499 employees) in Digital and deeptech, Clean Energy or Biotechnology? - seeking an investor that can invest €10 to 30 million for a major funding round? - already having qualified investors covering at least 20% of the target funding round? If yes to all three, check out the European Innovation Council (EIC) STEP ScaleUP scheme that is open to receive business plans and apply here ➡️europa.eu/!CYQcwV The EIC STEP Scale Up scheme is part of the Strategic Technologies for Europe Platform (STEP), offering financial support in the form of investments to startups, SMEs, and small mid-caps.
To view or add a comment, sign in
-
Here are the highlights of the startup funding trends for the past week 👇 Eight startups secured $100M+ rounds, showcasing diverse industry strength: 👉 Biotech and financial services led the pack 👉 Automotive, fintech, and IT software saw major investments 👉 Notably, no massive AI raises this week This trend indicates: 1. Continued investor confidence in breakthrough technologies across sectors 2. Resilience in non-AI verticals, demonstrating a balanced funding landscape 3. Potential shift towards more established industries alongside cutting-edge tech It's refreshing to see substantial capital flowing into a variety of sectors, fostering innovation beyond the AI hype. Below are the top 10 startups with highest funding of the week in the US 1. Cardurion Pharmaceuticals => US$ 260M 2. Human Interest => US$ 242M 3. Tekion Corp => US$ 200M 4. Saronic Technologies => US$ 175M 5. Scorpion Therapeutics => US$ 150M 6. Aven => US$ 142M 7. NGM Biopharmaceuticals => US$ 122M 8. Kandji => US$ 100M 9. Halo Industries, Inc. => US$ 80M 10. DreamBig Semiconductor Inc. => US$ 75M What are your thoughts on this week's funding trends? Are we seeing a recalibration in investor focus? source: Crunchbase #StartupFunding #VentureCapital #InnovationEconomy
To view or add a comment, sign in
-
MedTech Innovator Asia Pacific applications for our 2025 cohort are now open! Don't miss this chance to join the world's top accelerator for medical device and diagnostic companies. If you are based in or have a strategic interest in Asia Pacific this is the right program for you. #medtech #healthtech #digitalhealth #invitrodiagnostics #medtechinnovation #startups
🚨 The MedTech Innovator Asia Pacific 2025 Accelerator Program is now open for applications! 🎉 This is your moment to accelerate growth and drive impact across Asia Pacific! 🚀 What Our Program Includes: 🔹 Expert mentorship from industry leaders 🔹 Access to a dynamic network of partners and healthcare professionals 🔹 Tailored resources to fuel your venture's growth If you are ready to elevate your startup and make waves in the medtech space, apply today and take the first step toward transforming your vision into reality! 📅 Deadline: 15 January 2025 👉🏻 Apply here: https://lnkd.in/g3MYdc9z #Innovation #Healthcare #MedTech #MTIAPAC #MTIAPAC2025 #digitalhealth #invitrodiagnostics #startups
To view or add a comment, sign in
-
❓Got questions about our Medical Biotech Startup Program? We’ve got answers! If you’re a startup in medtech, biotech and techbio, join us on Dec 17th at 4:00 PM CET for an Ask Me Anything session 🚀 Here’s what’s in it for you: 🔍 Insights into application guidelines 🤝 Mentorship and expert support details 🌍 Overview of In-person ecosystem tours 💼 Information on investor days and partner offerings Learn how our 10-week hybrid program can help you scale faster and reach the market sooner. Register now and take the first step toward accelerating your innovation! 👉https://bit.ly/3BefEDA
To view or add a comment, sign in
-
𝗦𝘂𝘀𝘁𝗮𝗶𝗻𝗮𝗯𝗹𝗲 𝗜𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗼𝗻 𝗦𝗲𝗿𝗶𝗲𝘀 𝗦𝗲𝗮𝘀𝗼𝗻 4 𝗘𝗽𝗶𝘀𝗼𝗱𝗲 1 - 𝗪𝗵𝗮𝘁 𝗶𝘀 𝘁𝗵𝗲 𝗳𝘂𝘁𝘂𝗿𝗲 𝗼𝗳 𝗔𝗱𝘃𝗮𝗻𝗰𝗲𝗱 𝗠𝗮𝗻𝘂𝗳𝗮𝗰𝘁𝘂𝗿𝗶𝗻𝗴? The Sustainable Innovation Series is back with Season 4, featuring a fresh format and dynamic discussions. 🚀 In Episode 1, we delve into the future of Advanced Manufacturing, hosting thought leaders from diverse sectors to explore the evolving landscape driven by technological advancements. Andy Wong, Vice President, ADS/Segment Marketing Asia Pac, Avnet Dr. Mousumi Bhat, Advisor - Semiconductor, Singapore Deep-Tech Alliance (SDTA) Tejaswini Vaidya, Director Marketing / APAC Strategy, allnex Albert Sutiono 张自盛, Advisor - Manufacturing Singapore Deep-Tech Alliance (SDTA) 🔎 Topics covered include: - Innovation and Technology Overview in Manufacturing & Semiconductor Landscape - Pros and Cons of Centralised vs. Decentralised Manufacturing - Collaborative Partnerships between Industry Giants and Startups - Exciting Trends on the Horizon 𝗖𝗮𝘁𝗰𝗵 𝘁𝗵𝗲 𝗳𝘂𝗹𝗹 𝗲𝗽𝗶𝘀𝗼𝗱𝗲 𝗵𝗲𝗿𝗲: https://lnkd.in/gUDRfrm8 ------------------------------------------------------- If you're passionate about propelling high-growth ventures in advanced manufacturing and crave rapid market entry with global corporations, SDTA's venture building programme is your launchpad. Our Alliance Strategy unites industry expertise, market access, cutting-edge technologies, and funding to empower entrepreneurs like you to co-create and fast-track groundbreaking ventures. 𝗗𝗼𝗻'𝘁 𝗠𝗶𝘀𝘀 𝗢𝘂𝘁 - 𝗔𝗽𝗽𝗹𝗶𝗰𝗮𝘁𝗶𝗼𝗻 𝗼𝗽𝗲𝗻𝘀 𝘁𝗼𝗱𝗮𝘆! https://lnkd.in/gTtUvCBW #AdvancedManufacturing #SDTA #SustainableInnovation #VentureBuilding
To view or add a comment, sign in
-
I may be late to the game, but it suddenly hit me… Biotech is NOT science 🧬, it’s BUSINESS 💰 It may be very obvious to some, but to others, this is a very weird notion. Let’s unpack: Many believe that biotech is driven purely by INNOVATION, but behind every groundbreaking therapy is a complex web of PARTNERSHIPS and DEALS. Today, early-stage biotech startups are finding it harder to strike GOLD with pharma companies. The reason? Pharma companies are tightening their wallets, offering less upfront money and seeking more favorable TERMS in licensing agreements. In the past, startups could expect SIGNIFICANT upfront payments. Now, those payments are shrinking, pushing small companies to rethink their strategies. Yet, this isn't all bad news. The shift forces startups to be more STRATEGIC, ensuring their science is not just innovative, but also commercially viable from DAY ONE. Biotech is not just about developing a CURE; it’s about ensuring that cure reaches the market, drives profits, and sustains the business. The journey from lab to market is full of CHALLENGES, and navigating it successfully requires as much BUSINESS savvy as it does SCIENTIFIC brilliance. In the end, biotech is where science and business must BALANCE together. Which side of biotech industry do YOU work in and how do you view the other side? I’ll link the article that inspired me to make this post in the comments. #biotech #business #science #technology #innovation
To view or add a comment, sign in
-
The Deep Tech Incubator programme not only kickstarts new and innovative businesses, but also sets them up for future investment and long-term success. Read the report to find out more about the successful ventures that are emerging from the programme: https://lnkd.in/gZc_T3wH
To view or add a comment, sign in
93,783 followers
Reach out to the Corporate Engagement team at ce@sginnovate.com to explore how they can support your innovation journey.